CareDx: Q4 Earnings Snapshot

Associated Press Finance02-26

BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported fourth-quarter net income of $87.7 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Brisbane, California-based company said it had profit of $1.51. Earnings, adjusted for non-recurring gains, were 18 cents per share.

The molecular diagnostics company posted revenue of $86.6 million in the period.

For the year, the company reported net income of $52.5 million, or 93 cents per share, swinging to a profit in the period. Revenue was reported as $333.8 million.

CareDx expects full-year revenue in the range of $365 million to $375 million.

CareDx shares have declined slightly more than 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $21.10, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2514895669?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-02-27 05:56","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2514895669","market":"us","top_or_hot":-1,"title":"CareDx: Q4 Earnings Snapshot","media":"Associated Press Finance","content":"<html><body><p>BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — <a href=\"https://laohu8.com/S/CDNA\">CareDx</a> Inc. (CDNA) on Wednesday reported fourth-quarter net income of $87.7 million, after reporting a loss in the same period a year earlier.</p>\n<p>On a per-share basis, the Brisbane, California-based company said it had profit of $1.51. Earnings, adjusted for non-recurring gains, were 18 cents per share.</p>\n<p>The molecular diagnostics company posted revenue of $86.6 million in the period.</p>\n<p>For the year, the company reported net income of $52.5 million, or 93 cents per share, swinging to a profit in the period. Revenue was reported as $333.8 million.</p>\n<p>CareDx expects full-year revenue in the range of $365 million to $375 million.</p>\n<p>CareDx shares have declined slightly more than 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $21.10, more than doubling in the last 12 months.</p>\n<p>_____</p>\n<p>This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA</p></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CareDx: Q4 Earnings Snapshot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCareDx: Q4 Earnings Snapshot\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-27 05:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/caredx-q4-earnings-snapshot-215637006.html><strong>Associated Press Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported fourth-quarter net income of $87.7 million, after reporting a loss in the same period a year earlier.\nOn a per-...</p>\n\n<a href=\"https://finance.yahoo.com/news/caredx-q4-earnings-snapshot-215637006.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"https://finance.yahoo.com/news/caredx-q4-earnings-snapshot-215637006.html","article_id":"2514895669","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514895669","pubTimestamp":1740606997,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"BRISBANE, Calif.  — BRISBANE, Calif.  — CareDx Inc.  on Wednesday reported fourth-quarter net income of $87.7 million, after reporting a loss in the same period a year earlier.On a per-share basis, the Brisbane, California-based company said it had profit of $1.51. Earnings, adjusted for non-recurring gains, were 18 cents per share.The molecular diagnostics company posted revenue of $86.6 million in the period.For the year, the company reported net income of $52.5 million, or 93 cents per share, swinging to a profit in the period. Revenue was reported as $333.8 million.CareDx expects full-year revenue in the range of $365 million to $375 million.CareDx shares have declined slightly more than 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $21.10, more than doubling in the last 12 months.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx"},"translate_title":"CareDx：第四季度收益快照","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDNA":1},"content_text":"BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Wednesday reported fourth-quarter net income of $87.7 million, after reporting a loss in the same period a year earlier.\nOn a per-share basis, the Brisbane, California-based company said it had profit of $1.51. Earnings, adjusted for non-recurring gains, were 18 cents per share.\nThe molecular diagnostics company posted revenue of $86.6 million in the period.\nFor the year, the company reported net income of $52.5 million, or 93 cents per share, swinging to a profit in the period. Revenue was reported as $333.8 million.\nCareDx expects full-year revenue in the range of $365 million to $375 million.\nCareDx shares have declined slightly more than 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $21.10, more than doubling in the last 12 months.\n_____\nThis story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2514895669"}